CClinicalTrials.gg
Not yet recruitingNCT06277089Updated Feb 26, 2024

Curve Correction of Early Onset Scoliosis by Mehta Serial Casts

An interventional study of Casts in Scoliosis, sponsored by Assiut University. Not yet recruiting. Open to participants aged 3 Years to 10 Years. Per ClinicalTrials.gov, last updated 2024-02-26.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
3 Years to 10 Years
Sex
All
01

Study summary

Assessment of the role of Mehta Serial Casts in Curve Correction of Early Onset Scoliosis

Read the detailed description

Early Onset Scoliosis refers to various types of Scoliosis with onset before 10 years of age .In addition to spinal Deformity Progressive Scoliosis will also affect the development of thoracic cage and lungs . So Early correction is important .

Curve correction can done by operative and nonoperative techniques . Our Study include the curve correction by Mehta Serial Casts which not need for blood transfusion and has a good role in stop progression and delay the need for surgery .

02

Conditions studied

  • Scoliosis

Browse trials for

03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

This study's planned enrollment of 5 is below the median of 44 across 344 interventional studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All cases with Early Onset Scoliosis up to 10 years Age presenting to Assiut University Hospitals during 2 years period .

Exclusion criteria

Exclusion Criteria:

  • Cases with previous spine surgery and those whose guardians refuse to participate in the study .
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (estimated)

Study arms

  • Other
    Correction of EOS by serial cast

    Other: Casts

Interventions

  • OtherCasts

    According to level of scoliosis cast done and recast in a serial manner

06

What researchers measure

Primary outcomes

  1. Difference of the scoliotic cobb angle at last cast

    Measurement of Cobb angle in every visit and find the difference of the Scoliotic Cobb angle between first and last visit to assist the Correction ( Cobb angle measured by X Ray

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Thorsness RJ, Faust JR, Behrend CJ, Sanders JO. Nonsurgical Management of Early-onset Scoliosis. J Am Acad Orthop Surg. 2015 Sep;23(9):519-28. doi: 10.5435/JAAOS-D-14-00019. PubMed 26306805 ↗
  • Matsumoto H, Auran E, Fields MW, Hung CW, Hilaire TS, Roye B, Sturm P, Garg S, Sanders J, Oetgen M, Levine S, Roye D, Vitale M; Pediatric Spine Study Group. Serial casting for early onset scoliosis and its effects on health-related quality of life during and after discontinuation of treatment. Spine Deform. 2020 Dec;8(6):1361-1367. doi: 10.1007/s43390-020-00175-5. Epub 2020 Aug 5. PubMed 32757176 ↗
  • Mahajan R, Kishan S, Mallepally AR, Shafer C, Marathe N, Chhabra HS. Evolution of casting techniques in early-onset and congenital scoliosis. J Clin Orthop Trauma. 2020 Sep-Oct;11(5):810-815. doi: 10.1016/j.jcot.2020.06.034. Epub 2020 Jul 8. PubMed 32879567 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06277089
Lead sponsor
Assiut University
Responsible party
Ahmed Kamal Zohery (Assistant lecturer, Assiut University) — Principal investigator
First posted
Feb 26, 2024
Start date
Mar 1, 2024 (estimated)
Primary completion
Mar 1, 2025 (estimated)
Completion
Sep 1, 2025 (estimated)
Last update
Feb 26, 2024

Study contacts

Ahmed Kamal Zohery Darwish
Contact
ak290373@gmail.com
01023060980
Hesham Mohamed Elbaseet
Contact
01007780689
Mohammad Mostafa El Sharkawi
study director · Prof.dr
Nariman Elsayed Mohammad ABOL Oyoun
study director · Prof.dr

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion